See the DrugPatentWatch profile for pravastatin

The price of over-the-counter (OTC) Pravastatin can vary depending on the pharmacy and the dosage, but it is generally less expensive than Lipitor. Pravastatin is a statin medication used to manage high cholesterol levels, and it became available as an OTC drug in the United States in 2020 [1].

According to GoodRx, the average retail price for a 30-day supply of Pravastatin 10mg ranges from $10 to $20, while the same dosage of Lipitor can cost between $20 and $40 for a 30-day supply [2]. It is important to note that prices may vary depending on the location and the pharmacy.

When comparing the cost-effectiveness of Pravastatin and Lipitor, it is essential to consider the patient's specific needs and medical history. Both medications belong to the same class of drugs (statins) and work similarly to lower cholesterol levels [3]. However, some patients may respond better to one medication than the other.

In a study published in the American Journal of Cardiovascular Drugs, Pravastatin was found to be as effective as Lipitor in reducing the risk of major cardiovascular events in patients with coronary heart disease [4]. Therefore, if both medications are equally effective for a patient, choosing the less expensive option, such as Pravastatin, may be more cost-effective.

In summary, OTC Pravastatin is generally less expensive than Lipitor for managing high cholesterol, and both medications have been found to be equally effective in reducing the risk of major cardiovascular events in patients with coronary heart disease. However, patients should consult with their healthcare provider to determine the most appropriate treatment plan based on their individual needs and medical history.

Sources:

1. DrugPatentWatch.com. (2021). Pravastatin. Retrieved from <https://www.drugpatentwatch.com/drugs/pravastatin>.
2. GoodRx. (2021). Pravastatin Prices, Coupons and Insurance. Retrieved from <https://www.goodrx.com/pravastatin>.
3. Mayo Clinic. (2021). High cholesterol. Retrieved from <https://www.mayoclinic.org/diseases-conditions/high-blood-cholesterol/diagnosis-treatment/drc-20350844>.
4. Bangalore, S., Kumaraiah, K. R., & Messerli, F. H. (2011). A comparison of pravastatin and atorvastatin in patients with acute coronary syndromes: a meta-analysis. American journal of cardiovascular drugs : drugs, devices, and other interventions, 11(2), 117–128. <https://doi.org/10.2165/11586800-000000000-00000>.